JP Morgan Chase
SMTI icon

JP Morgan Chase’s Sanara MedTech SMTI Stock Holding History

JP Morgan Chase’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Sell
6,290
-717
-10% -$14.8K ﹤0.01% 5780
2025
Q4 		$164K Sell
7,007
-4,050
-37% -$105K ﹤0.01% 5631
2025
Q3 		$351K Buy
11,057
+2,315
+26% +$69.9K ﹤0.01% 5223
2025
Q2 		$248K Sell
8,742
-2,978
-25% -$89.3K ﹤0.01% 5136
2025
Q1 		$362K Sell
11,720
-1,854
-14% -$62.9K ﹤0.01% 4964
2024
Q4 		$451K Buy
13,574
+9,516
+234% +$323K ﹤0.01% 5093
2024
Q3 		$123K Buy
4,058
+2,272
+127% +$70.9K ﹤0.01% 5614
2024
Q2 		$50.4K Buy
1,786
+180
+11% +$5.65K ﹤0.01% 5857
2024
Q1 		$59.4K Sell
1,606
-1,164
-42% -$43.5K ﹤0.01% 5870
2023
Q4 		$114K Buy
2,770
+309
+13% +$9.92K ﹤0.01% 5673
2023
Q3 		$76.6K Sell
2,461
-564
-19% -$21.8K ﹤0.01% 5633
2023
Q2 		$121K Sell
3,025
-148
-5% -$6.05K ﹤0.01% 5373
2023
Q1 		$131K Buy
+3,173
New +$134K ﹤0.01% 5301

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase's SMTI Position: Q1 2026 in Review

JP Morgan Chase reduced its Sanara MedTech (SMTI) stake by 10% in Q1 2026, selling an estimated $14.8K and leaving 6,290 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #5780.

JP Morgan Chase first reported a position in SMTI in Q1 2023 and has held it in 13 quarters since. The position peaked at $451K in Q4 2024. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • JP Morgan Chase held 6,290 shares of Sanara MedTech worth $109K as of Q1 2026.
  • JP Morgan Chase sold 717 Sanara MedTech shares in Q1 2026, an estimated $14.8K.
  • Sanara MedTech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5780 holding.
  • JP Morgan Chase first reported a position in Sanara MedTech in Q1 2023 and has held it in 13 quarters since.
  • JP Morgan Chase's Sanara MedTech position peaked at $451K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.